Understanding the potential synergistic effects of HIF-1 on cells in the cancer milieu with other tumor-associated factors like TGF-β, IL-1, hormones, and growth factors is another important direction for multitargeted approaches and for development of safe biological therapies. The gene discussed is HIF1A; the disease is neoplasm.